SNTI earnings date and last-quarter result: last quarter beat, P/E -0.23. Updated 2026-07-23.
Senti Biosciences (SNTI) Research Hub
Senti Biosciences (SNTI) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.1751 USD (-7.06%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.23, market cap 0.01B. This hub links to the full technical, earnings and options research available for SNTI.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.1751 USD (-7.06%) |
| 52-week range | 0.1701 USD – 1.15 USD |
| Trend regime | Range |
| 14-day RSI | 16 (Oversold) |
| Trailing P/E | -0.23 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
Available research for SNTI
Covered Call on SNTI: how it works, illustrative setup around the real 0.1751 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SNTI: how it works, illustrative setup around the real 0.1751 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SNTI: how it works, illustrative setup around the real 0.1751 USD price, max profit/loss, breakeven and when to use it. Educational.
SNTI technical analysis: range, last 0.1751 USD, RSI 16, 52w range 0.1701 USD–1.15 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SNTI in?
Senti Biosciences (SNTI) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SNTI in an uptrend or downtrend?
As of 2026-10-26, SNTI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SNTI's trailing P/E ratio?
SNTI's trailing P/E is -0.23, with a market cap of 0.01B. See the earnings research page for full valuation detail.